This course is expiring, etc. etc. etc.
CE Credit Hours: 1.50 CPEUs (1.00 CPEUs for Florida licenses)
Commission on Dietetic Registration (CDR) - Provider #21328, Activity #135656 approved for 1.50 CPEUs.
CEU Course Description
Visceral fat-type obesity induces type-2 diabetes mellitus, hyperlipidemia, hypertension, and increases the risk of cardiovascular disease. Subcutaneous fat-type obesity is associated with excessive weight gain, and is thought to be the main risk factor for osteoarthritis of the knee, sleep apnea, and menstrual abnormalities. Due to the numerous consequences of increased fat mass, this CEU course evaluates the anti-obesity effect of glucosyl hesperidin plus caffeine on body fat and serum triglyceride in healthy subjects with moderately high body mass index and serum triglyceride.
Article Author: Tatsuya Ohara, et al.; House Wellness Foods Corporation
Exam writer: Tiev LaGuire, M.S.
Brooke H. Dekofsky, MPH, RD, CLE, CDE was involved in the creation of this course.
CEU Course Objectives
1. Explain the mechanism of the TG-lowering effect of G-hesperidin.
2. Compare and contrast the statistically significant results found between G-hesperidin and placebo groups.
3. Examine how G-hesperidin and caffeine reduce the accumulation of body fat.
4. Identify, when mixed, which components have been shown to have an anti-obesity effect in humans with a high BMI.
CPE Level: II
Learning Codes: 2010, 4040, 5160, 5190
Performance Indicators (RDN): 8.1.3 , 8.1.5 , 8.3.1 , 8.3.4
Did you know you can now get UNLIMITED CPEUs for only $75/year?
Click Here to learn more.
Our courseware includes the text content found on our websites as well as video, audio, and exam questions that make up our courses. You can link to and access our courseware free of charge for personal use. You may not modify or redistribute our courseware under any circumstances.
Although we allow free access for personal use, you may not use our courseware for any commercial purposes without an agreement in place. This includes (but is not limited to) using our courseware for internal training, redistributing our courseware for sale, and copying all or parts of any of our courseware.
If you're interested in licensing our content for commercial purposes or have any other questions, please contact email@example.com.
We will disclose, in advance, any proprietary interest in any product, instrument, device, service, or material to be discussed during the learning event, as well as the source of any third-party compensation related to the presentation. This policy applies to both our organization and contractors. If such proprietary/financial interests exist, we will publish a disclaimer in marketing or instructional materials for a course.
In order to view this course, you will need to be able to view a PDF document for the course material. If your device doesn't have the capability to view a PDF, you can click here to download Adobe Acrobat for free.
The board approval status information is provided based on our current understanding of the licensing agencies. Please note that it is the responsibility of each licensee to verify acceptance of our courses with their licensing agency.